{"id":"il-yang-flu-vaccine-prefilled-syringe","safety":{"commonSideEffects":[{"rate":"10–30%","effect":"Injection site pain, redness, or swelling"},{"rate":"5–15%","effect":"Myalgia (muscle pain)"},{"rate":"5–10%","effect":"Headache"},{"rate":"5–10%","effect":"Fatigue"},{"rate":"1–5%","effect":"Low-grade fever"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"As an inactivated influenza vaccine in prefilled syringe form, it contains antigens from seasonal flu virus strains that trigger both humoral (antibody) and cell-mediated immune responses. This prepares the immune system to recognize and rapidly neutralize circulating influenza viruses, reducing infection risk and disease severity.","oneSentence":"IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:48:17.002Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal influenza prevention in adults and/or pediatric populations"}]},"trialDetails":[{"nctId":"NCT04381689","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2024-10-23","conditions":"Healthy","enrollment":245},{"nctId":"NCT02677493","phase":"PHASE3","title":"Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2015-10","conditions":"Influenza","enrollment":1794},{"nctId":"NCT02263131","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Children","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2013-10","conditions":"Healthy","enrollment":416},{"nctId":"NCT02330003","phase":"PHASE1","title":"Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2013-05","conditions":"Healthy","enrollment":100},{"nctId":"NCT02154308","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults","status":"COMPLETED","sponsor":"Il-Yang Pharm. Co., Ltd.","startDate":"2012-11","conditions":"Healthy","enrollment":787}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"IL-YANG Flu Vaccine Prefilled Syringe","genericName":"IL-YANG Flu Vaccine Prefilled Syringe","companyName":"Il-Yang Pharm. Co., Ltd.","companyId":"il-yang-pharm-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"IL-YANG Flu Vaccine stimulates the immune system to produce antibodies and cellular immunity against influenza virus strains included in the vaccine formulation. Used for Seasonal influenza prevention in adults and/or pediatric populations.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}